Synthesis and evaluation of novel daunomycin-phosphate-sulfate -β-glucuronide and -β-glucoside prodrugs for application in adept
- 1 December 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (24) , 2975-2980
- https://doi.org/10.1016/0960-894x(95)00523-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Design of Antitumor Prodrugs: Substrates for Antibody Targeted EnzymesChemical Reviews, 1994
- Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugatesTrends in Biotechnology, 1994
- Antibody-directed enzyme prodrug therapy (Adept)Journal of Controlled Release, 1994
- Generation of cytotoxic agents by targeted enzymesBioconjugate Chemistry, 1993
- A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancerBritish Journal of Cancer, 1992
- Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugateBiochemical Pharmacology, 1991
- In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphateBioconjugate Chemistry, 1991
- The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancerBioconjugate Chemistry, 1990
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- MONOCLONAL ANTIBODIES IN CANCER TREATMENTThe Lancet, 1986